Artax Biopharma, Inc. — Form D

Artax Biopharma, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-04. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (46)

Showing 25 of 46 people.

NameRoleLocation
Robert E Armstrong, Ph.D.DirectorCambridge, MA
Javier M GarciaDirectorCambridge, MA
Damia W Tormo, Ph.D.DirectorCambridge, MA
Alan W WaltsDirectorCambridge, MA
Raj W ParekhDirectorCambridge, MA
Robert W Armstrong, Ph.D.DirectorCambridge, MA
Robert W Armstrong, Ph.D.Executive OfficerCambridge, MA
Joe W SuarezExecutive OfficerCambridge, MA
Andre W HoekemaDirectorCambridge, MA
Maria W NicholExecutive OfficerCambridge, MA
Casper W BreumDirectorCambridge, MA
Gino W SantiniDirectorCambridge, MA
Gino SantiniDirectorCambridge, MA
Gino SantiniRelated PersonCambridge, MA
Robert ArmstrongDirectorCambridge, MA
Robert ArmstrongExecutive OfficerCambridge, MA
Damia TormoDirectorCambridge, MA
Damia TormoExecutive OfficerCambridge, MA
Casper BreumDirectorNESS ZIONA, L3
Casper BreumRelated PersonNESS ZIONA, L3
Alan WaltsDirectorCambridge, MA
Alan WaltsRelated PersonCambridge, MA
Andre HoekemaDirectorCambridge, MA
Andre HoekemaRelated PersonCambridge, MA
Maria NicholExecutive OfficerCambridge, MA

Other filings by this issuer (10)

FiledFormOfferingSold
2026-05-05D/A$19.0M$19.0M
2025-07-29D/A$11.0M$11.0M
2024-08-09D$8.0M$6.0M
2022-05-18D/A$25.8M$25.8M
2022-01-03D$23.2M$12.7M
2021-02-26D$3.0M$2.2M
2019-08-12D$3.5M$750K
2015-10-27D$10.0M$3.0M
2014-11-10D$2.0M$2.0M
2013-09-25D$2.0M$1.3M

More